Epilepsy & Seizures
FDA/CDC
FDA warns of potentially lethal reaction to seizure meds
Diagnosis is often difficult because early signs and symptoms, such as fever and swollen lymph nodes, may be present without evidence of a rash....
Latest News
New consensus guide on rare drug hypersensitivity reaction
To support clinicians in diagnosing and managing DRESS, a steering committee conducted a literature review to examine current research, identify...
Literature Review
Yoga linked to seizure, anxiety reduction in epilepsy
“Our study showed that doing yoga can alleviate the burden of epilepsy and improve the overall quality of life by reducing this perceived stigma...
Conference Coverage
Artificial intelligence presents opportunities, challenges in neurologic practice
Programs can generate health care and research content, but require close supervision and an attitude of ‘trust, but verify.’
Literature Review
RNA therapeutics will ‘change everything’ in epilepsy
“We now have the potential to change the way genetic epilepsies are treated by addressing the underlying genetic cause of the disease instead of...
Sponsored Supplement
Predicting Efficacy of AEDs in Children: Extrapolation of Data From Adult Clinical Trials
Latest News
Neurologic nuggets of wisdom for pediatric practice
Overall, actual seizures are less common than other neurologic events in children.
Latest News
New European restrictions on topiramate in pregnancy
For patients using topiramate for the treatment of epilepsy, the PRAC now recommends that the medicine not be used during pregnancy.
Conference Coverage
Global burden of brain disorders surpasses cardiovascular disease and cancer
“The burden of brain conditions will increase as populations continue to grow and age.”
Latest News
AI model interprets EEGs with near-perfect accuracy
The technology distinguishes between abnormal and normal EEG recordings and classifies irregular recordings into specific categories crucial for...
Commentary
New DEA CME mandate affects 2 million prescribers
One should not underestimate the sweeping scope of this new federal requirement.
Conference Coverage
Noninvasive testing in midlife flags late-onset epilepsy risk
The study could help identify at-risk individuals years before symptoms of epilepsy appear.